Related Experiment Video

Updated: Jun 29, 2026

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia
09:35

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia

Published on: November 15, 2024

[Specificity of hyperglycemia treatment in acute stroke patients]

Ivan Bielen1, Ana Sruk, Damir Zalac

  • 1Zavod za neurologiju, Opća bolnica Sveti Duh, Zagreb, Hrvatska.

Acta Medica Croatica : Casopis Hravatske Akademije Medicinskih Znanosti
|October 11, 2008
PubMed

Insights

Hyperglycemia in acute stroke patients is common and linked to poor outcomes, but its independent role and optimal treatment remain uncertain. Further research is needed for clear clinical guidelines.

Area of Science:

  • Neurology
  • Endocrinology
  • Critical Care Medicine

Context:

  • Hyperglycemia is prevalent in acute stroke patients, with varying clinical guideline recommendations between Europe and the USA.
  • Existing literature suggests a correlation between hyperglycemia and adverse clinical outcomes, including impaired thrombolysis.
  • Pathophysiological mechanisms linking hyperglycemia to cerebral damage are complex and not fully elucidated.

Purpose:

  • To review key findings and unresolved questions regarding the acute management of hyperglycemia in stroke patients.
  • To highlight discrepancies in current European and US clinical guidelines for stroke hyperglycemia treatment.

Summary:

  • High prevalence of glucose dysregulation in stroke patients is noted, with evidence linking hyperglycemia to poor outcomes and thrombolysis effects.
  • Contradictory data exist on hyperglycemia's direct role in cerebral damage, with potential involvement of lactic acidosis.
  • Insulin therapy shows promise in critically ill patients, but definitive evidence for strict hyperglycemia control improving stroke outcomes is lacking.

Impact:

  • Current evidence is insufficient to determine if hyperglycemia is an independent predictor of poor stroke outcome or a marker of severity.
  • The exact blood glucose threshold for predicting adverse outcomes requires further definition.
  • Ongoing trials are expected to refine clinical guidelines for managing hyperglycemia in acute stroke, addressing risks of hypoglycemia and metabolic disorders.
Abstract

More Related Videos

Improving IV Insulin Administration in a Community Hospital12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...